iX Biopharma Ltd. announced the availability of a formal exercise notice for holders of its outstanding warrants.

The document states that the warrants allow subscription for new ordinary shares at an exercise price of 0.06 million Singapore dollars per share and will expire at 5:00 p.m. on Jul, 18 2026, or the preceding market day if that date is not a trading day.

Under the terms, warrant holders must submit the completed notice, together with payment via banker’s draft, cashier’s order, or bank transfer, to Tricor Barbinder Share Registration Services. Upon exercise, new shares will be allotted to The Central Depository (Pte) Limited for credit to the respective securities accounts.

The company highlighted that all documents will be dispatched by ordinary post at the investor’s risk and reminded corporate applicants to affix their common seal in line with their constitutions.